Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

ES Winkler, AL Bailey, NM Kafai, S Nair… - Nature …, 2020 - ncbi.nlm.nih.gov
ES Winkler, AL Bailey, NM Kafai, S Nair, BT McCune, J Yu, JM Fox, RE Chen, JT Earnest
Nature immunology, 2020ncbi.nlm.nih.gov
In the version of this article initially published, in the Methods section “Tumor growth and
treatments,” a description of the vehicle used as the control treatment (no emricasan) was
omitted. For the emricasan dissolved in 2% alginate in PBS treatment, the corresponding
vehicle control was 2% alginate in PBS without emricasan. For the emricasan dissolved in
PBS treatment, the corresponding vehicle control was PBS without emricasan. The error has
been corrected in the HTML and PDF versions of the article.
In the version of this article initially published, in the Methods section “Tumor growth and treatments,” a description of the vehicle used as the control treatment (no emricasan) was omitted. For the emricasan dissolved in 2% alginate in PBS treatment, the corresponding vehicle control was 2% alginate in PBS without emricasan. For the emricasan dissolved in PBS treatment, the corresponding vehicle control was PBS without emricasan. The error has been corrected in the HTML and PDF versions of the article.
ncbi.nlm.nih.gov